Surgical Strategy for the Treatment of Medullary Thyroid Carcinoma
- 1 November 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 230 (5) , 697-707
- https://doi.org/10.1097/00000658-199911000-00013
Abstract
To evaluate surgical complications, patterns of lymph node metastases, and calcitonin response to compartment-oriented lymphadenectomy in patients with primary or recurrent medullary thyroid carcinoma (MTC). The majority of patients with invasive MTC have metastasis to regional lymph nodes at the time of diagnosis, as evidenced by the frequent finding of persistently elevated calcitonin levels after thyroidectomy and the high rates of recurrence in the cervical lymph nodes reported in retrospective studies. These data have provided the rationale for surgeons to perform a more extensive lymphadenectomy at the time of initial thyroidectomy and to consider reoperative cervical lymphadenectomy in patients with persistently elevated calcitonin levels after thyroidectomy. Forty patients underwent surgery for MTC from 1991 to 1997 (23 sporadic cases, 17 familial cases). Patients were divided into three groups based on whether they had undergone previous thyroidectomy and on the results of standardized staging studies performed after referral to the authors’ institution. Group 1 (11 patients) had received no previous surgery; group 2 (13) underwent thyroidectomy before referral and had an elevated calcitonin level without radiologic evidence of local-regional or distant metastases; and group 3 (16) underwent thyroidectomy before referral and had an elevated calcitonin level with radiologic evidence of local-regional recurrence. The central neck compartment was dissected in all patients; preoperative staging and the extent of previous surgery dictated the need for lateral (modified radical) neck dissection. After primary or reoperative surgery, calcitonin levels were assessed. All patients had major reductions in postoperative calcitonin levels. Seven (29%) of 24 patients in groups 1 and 2 achieved normal calcitonin values compared with only 1 (6%) of 16 in group 3. Postoperative complications included seven cases (17%) of permanent hypoparathyroidism; five (71%) of these occurred in group 3. There were no iatrogenic recurrent laryngeal nerve injuries; one patient required recurrent nerve resection to achieve complete tumor extirpation. At a median follow-up of 35 months, local recurrence was documented in 5 (13%) of 40 patients. Compartment-oriented lymphadenectomy performed early in the course of MTC is safe and may return calcitonin levels to normal in up to 25% of carefully selected patients. However, reoperation for bulky cervical disease (group 3) rarely results in normal calcitonin levels and is associated with a high incidence of permanent hypoparathyroidism.Keywords
This publication has 24 references indexed in Scilit:
- Medullary Thyroid Cancer: Analyses of Survival and Prognostic Factors and the Role of Radiation Therapy in Local ControlThyroid®, 1996
- APPLICATION OF GENETIC SCREENING INFORMATION TO THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 2Endocrinology and Metabolism Clinics of North America, 1996
- Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levelsSurgery, 1996
- Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancerSurgery, 1995
- Surgical management and follow‐up of medullary thyroid carcinomaJournal of Surgical Oncology, 1995
- Microsurgical neck dissection for metastasizing medullary thyroid carcinomaEuropean Journal of Surgical Oncology, 1995
- Medullary Thyroid Carcinoma: Clinicopathologic Features and Long-Term Follow-Up of 65 Patients Treated During 1946 Through 1970Mayo Clinic Proceedings, 1992
- Localization of Occult Persisting Medullary Thyroid Carcinoma Before Microsurgical Reoperation: High Sensitivity of Selective Venous CatheterizationThyroid®, 1992
- Medullary Carcinoma of the ThyroidMedicine, 1984
- Management of medullary carcinoma of the thyroidThe American Journal of Surgery, 1982